Additional effects of pioglitazone in the patients with type 2 diabetes treated with biphasic insulin therapy

Medicine & Life Sciences

• Biphasic Insulins 100%
• Pioglitazone 82%
• Type 2 Diabetes Mellitus 48%
• Brain Natriuretic Peptide 36%
• Insulin 27%
• Lipid Metabolism 23%
• Glucose 15%
• Therapeutics 10%
• Weight Gain 7%
• HDL Cholesterol 7%
• Hemoglobins 6%
• Fasting 6%
• Observational Studies 6%
• Body Weight 5%
• Prospective Studies 5%